S&P 500 Futures
(0.72%) 5 366.25 points
Dow Jones Futures
(0.20%) 39 862 points
Nasdaq Futures
(1.21%) 19 014 points
Oil
(0.86%) $78.24
Gas
(0.11%) $2.85
Gold
(-1.20%) $2 364.10
Silver
(-2.40%) $30.74
Platinum
(-0.34%) $1 046.10
USD/EUR
(-0.25%) $0.921
USD/NOK
(-0.83%) $10.61
USD/GBP
(-0.11%) $0.785
USD/RUB
(0.31%) $90.48

Realtime updates for Calithera Biosciences Inc [CALA]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology
Last Updated22 May 2024 @ 11:14

0.00% $ 0.0200

Live Chart Being Loaded With Signals

Commentary (22 May 2024 @ 11:14):

Calithera Biosciences, Inc., a clinical-stage bio-pharmaceutical company, focuses on the discovery and development of small molecule compounds for tumor metabolism and tumor immunology targets for the treatment of cancer in the United States...

Stats
Today's Volume 9 987.00
Average Volume 1 367.00
Market Cap 97 450.00
EPS $0 ( 2024-03-29 )
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E 0
ATR14 $0 (0.00%)
Insider Trading
Date Person Action Amount type
2023-04-17 Takeda Pharmaceutical Co Ltd Sell 1 000 000 Series A Convertible Preferred Stock
2023-01-27 Pakianathan Deepika Sell 1 172 Common Stock
2023-01-23 Sjogren Eric Sell 279 Common Stock
2023-01-23 Kuriakose Emil Sell 79 Common Stock
2023-01-23 Molineaux Susan Sell 526 Common Stock
INSIDER POWER
-58.37
Last 99 transactions
Buy: 6 839 475 | Sell: 3 539 228

Calithera Biosciences Inc Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Calithera Biosciences Inc Financials

Annual 2022
Revenue: $0
Gross Profit: $0 (0.00 %)
EPS: $-3.78
FY 2022
Revenue: $0
Gross Profit: $0 (0.00 %)
EPS: $-3.78
FY 2021
Revenue: $9.75M
Gross Profit: $9.75M (100.00 %)
EPS: $-31.16
FY 2020
Revenue: $0.00
Gross Profit: $0.00 (0.00 %)
EPS: $-26.20

Financial Reports:

No articles found.

Calithera Biosciences Inc Options Data

Calls

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Puts

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Calithera Biosciences Inc

Calithera Biosciences, Inc., a clinical-stage bio-pharmaceutical company, focuses on the discovery and development of small molecule compounds for tumor metabolism and tumor immunology targets for the treatment of cancer in the United States. The company offers INCB001158, an orally bioavailable arginase inhibitor of arginase that is in Phase 1/2 clinical trial for the treatment of hematology and oncology. It is developing CB-280, an oral arginase inhibitor that has completed Phase 1b clinical trial for the treatment of cystic fibrosis and chronic airway infection; and ATG-037, an orally-bioavailable small molecule inhibitor of CD73, as well as CB-668, an orally administered inhibitor of the enzyme IL4I1. The company has a license agreement with Mars, Inc. to develop and commercialize Symbioscience's portfolio of arginase inhibitors for use in human healthcare. It also has clinical trial collaboration with Pfizer to evaluate Pfizer's PARP inhibitor talazoparib and CDK4/6 inhibitor palbociclib, each in combination with telaglenasta. In addition, the company has a collaboration and license agreement with Incyte Corporation for the research, development, and commercialization of INCB001158, a small molecule arginase inhibitor for the treatment of hematology and oncology; and a license agreement with Antengene Corporation Ltd. for the development and commercialization of CB-708. Calithera Biosciences, Inc. was incorporated in 2010 and is headquartered in South San Francisco, California.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators